Buy This “Waaaait for It” Stock on October 7 to Lock in Increased Dividend
Last month, I outlined two events we’d need to see to know the stock was headed up. Both have happened. Bonus: increased quarterly dividend!
Posted by Adam O'Dell | Oct 7, 2020 | Investing
Last month, I outlined two events we’d need to see to know the stock was headed up. Both have happened. Bonus: increased quarterly dividend!
Posted by Adam O'Dell | Oct 5, 2020 | Stocks
Click here to download the list in Microsoft Excel. Adam O’Dell’s High-Beta Bombs (Oct. 2020) Ticker Name Sector Industry ABUS Arbutus Biopharma Corp HEALTH CARE BIOPHARMASYS ACRX AcelRx Pharmaceuticals Inc...
Read MorePosted by Adam O'Dell | Oct 5, 2020 | Investing
Four qualities of high-beta stock bombs: small, high-beta, high-growth and unprofitable. Check out over 170 stocks to avoid today.
Posted by Adam O'Dell | Oct 1, 2020 | Investing
Biotech stocks are soaring as companies search for a coronavirus vaccine. This company has doubled since May — and could go even higher.
Posted by Adam O'Dell | Sep 28, 2020 | Investing
Health care stocks disruptor alert: Genomics stocks will disrupt Big Pharma in the same way Netflix killed Blockbuster video.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below